This report provides comprehensive information on the therapeutic development for Age Related Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration and special features on late-stage and discontinued projects.
Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=403557 . (This is a premium report price at US$2000 for a single user PDF license)
The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Inquire more about this report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=403557 .
- The report provides a snapshot of the global therapeutic landscape of Age Related Macular Degeneration
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Age Related Macular Degeneration and enlists all their major and minor projects
- A review of the Age Related Macular Degeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report summarizes all the dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
Reasons to buy:
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Age Related Macular Degeneration
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Age Related Macular Degeneration pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Inquire for discount of this report at http://www.rnrmarketresearch.com/contacts/discount?rname=403557 . (This is a premium report price at US$2000 for a single user PDF license)
Table of Contents:
Table of Contents 2
Age Related Macular Degeneration Overview 8
Therapeutics Development 9
Age Related Macular Degeneration - Therapeutics under Development by Companies 11
Age Related Macular Degeneration - Therapeutics under Investigation by Universities/Institutes 22
Age Related Macular Degeneration - Pipeline Products Glance 25
Age Related Macular Degeneration - Products under Development by Companies 29
Age Related Macular Degeneration - Products under Investigation by Universities/Institutes 41
Age Related Macular Degeneration - Companies Involved in Therapeutics Development 43
Age Related Macular Degeneration - Therapeutics Assessment 152
Drug Profiles 168
Age Related Macular Degeneration - Recent Pipeline Updates 430
Age Related Macular Degeneration - Dormant Projects 545
Age Related Macular Degeneration - Discontinued Products 555
Age Related Macular Degeneration - Product Development Milestones 556
More reports Ophthalmology Diseases are available at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics .
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.